• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Dis Ther . Burden of Respiratory Syncytial Virus in Older ADults in Nagasaki, Japan (Nagasaki ROAD): Preliminary Results (April 2024-March 20

tetano

Editor, Senior Moderator
Infect Dis Ther


. 2026 Apr 10.
doi: 10.1007/s40121-026-01312-9. Online ahead of print.
Burden of Respiratory Syncytial Virus in Older ADults in Nagasaki, Japan (Nagasaki ROAD): Preliminary Results (April 2024-March 2025) of a Prospective, Multicenter, Epidemiological Study

Takahiro Takazono[SUP] 1 2 [/SUP], Norihito Kaku[SUP] 3 4 [/SUP], Naoki Hosogaya[SUP] 1 5 [/SUP], Kiyoyasu Fukushima[SUP] 6 [/SUP], Ryota Takao[SUP] 7 [/SUP], Naoki Iwanaga[SUP] 1 8 [/SUP], Takuya Izumikawa[SUP] 9 [/SUP], Mai Kato[SUP] 10 [/SUP], Kentaro Tajima[SUP] 11 [/SUP], Yufan Ho[SUP] 12 [/SUP], Katsunori Yanagihara[SUP] 3 4 [/SUP], Hiroshi Mukae[SUP] 1 8 [/SUP]


Affiliations
Abstract

Introduction: Older adults (OAs) and individuals with underlying comorbidities are at increased risk for severe respiratory syncytial virus (RSV) disease (e.g., lower respiratory tract disease [LRTD]) and related adverse outcomes. However, RSV is underdiagnosed and underestimated in OAs, posing a growing concern in super-aged societies like Japan.
Methods: This prospective, multicenter, epidemiological study (Nagasaki ROAD) aimed to enroll approximately 2700 participants aged ≥ 50 years with acute respiratory infection (ARI) seeking care at outpatient/emergency/inpatient settings at 15 medical institutions/hospitals/clinics in Nagasaki and its surroundings. Enrolled participants were followed for 180 days. RSV positivity in nasopharyngeal swab samples, detected by reverse transcription polymerase chain reaction, served as the primary diagnosis of RSV-related ARI/LRTD (RSV-ARI/LRTD). Hospital-wide and non-hospital-wide screening were adopted based on site-level operational realities and clinical workflows.
Results: Data at enrollment (baseline/day 1) were analyzed from 1056 participants who were recruited between April 1, 2024 and March 31, 2025. The approximate positivity rate of RSV-ARI was 5.0% (n = 53), peaking from June to September 2024. The approximate positivity rate of SARS-CoV-2-ARI was 25.4% (n = 268), and influenza-ARI was 19.6% (n = 207). Hospitalization at or within 7 days of day 1 was observed in 20.8% (n = 11) of participants with RSV-ARI, 13.1% (n = 35) with SARS-CoV-2-ARI, and 13.0% (n = 27) with influenza-ARI. The most common comorbidities-of-interest were asthma (17.0% [n = 9]), chronic obstructive pulmonary disease (15.1% [n = 8]), and type 2 diabetes mellitus (7.5% [n = 4]) in participants with RSV-ARI. The observed need for oxygen supplementation was higher in participants with RSV-ARI (13.2% [n = 7]) than with SARS-CoV-2-ARI (3.4% [n = 9]) or influenza-ARI (8.7% [n = 18]).
Conclusions: These year 1 results contextualize the RSV disease burden in OAs aged ≥ 50 years in Nagasaki, Japan, providing an important basis for understanding RSV in Japanese OAs; findings complement existing evidence. Future analyses of all clinical outcomes through 180-day follow-up could further inform targeted prevention strategies in this population.

Keywords: Acute respiratory infection; Disease burden; Epidemiology; Japan; Older adults; Positivity rate; Prospective cohort study; Respiratory syncytial virus; Reverse transcription polymerase chain reaction; Upper and lower respiratory tract disease.

 
Back
Top